Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921

NCT03298061 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Churg-Strauss Syndrome
Eosinophilic Granulomatosis With Polyangiitis

Interventions

DRUG: Mepolizumab
DRUG: Prednisolone

Sponsor

GlaxoSmithKline